Harbor Healthcare Advises Behavioral Health LTC Pharmacy On Its Sale
Eastern USA • April 2024 Harbor Healthcare Consultants, a leading healthcare advisory firm, is pleased to announce the successful completion of the acquisition of a dual-location long-term care (“LTC”) pharmacy focused on behavioral health by a leading private equity-backed strategic acquirer. The acquisition, facilitated by Harbor Healthcare, spans operations across two eastern US states and […]
MoreHarbor Healthcare Advises American Integrative Compounding Pharmacy On Its Sale
Los Angeles, CA – 2024 – American Integrative Pharmacy, a distinguished 503A Compounding Pharmacy based in Los Angeles, California, and specializing in mental health, hormones, and women’s health, officially announced its acquisition by a nationwide pharmacy. The strategic purchase further accelerates the acquirer’s continued growth and expansion in the 503A compounding industry. Harbor Healthcare Consultants […]
MoreHarbor Healthcare Announces the Successful Sale of California’s Largest Independent Behavioral Health Pharmacy
California, 2023 – Harbor Healthcare Consultants, a leading M&A advisory firm specializing in healthcare and pharmacy transactions, proudly announces the successful sale of California’s largest independent behavioral health pharmacy services company, to a leading Private Equity acquirer with extensive experience and expertise in the healthcare space. This milestone transaction reflects the culmination of strategic efforts […]
More2023 Compounding Pharmacy M&A Market Update – How USP 800, Semaglutide And Competitive Forces Will Shape The Industry
This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader economy created challenges for transactions and Semaglutide created a boom for sellers. but pause for buyers. However, as the year progressed, anxiety dissipated, and buyers resumed their acquisition mandates. Last but not least, the constant […]
MoreHarbor Healthcare Advises La Vita Compounding On Its Sale & Strategic Partnership
San Diego, November 2023 – La Vita Compounding Pharmacy, a trusted 503A compounding pharmacy, is proud to announce its acquisition by a strategic buyer. The acquisition comes as part of the buyer’s strategic vision to build a national platform in the compounding pharmacy industry, leveraging the expertise and reputation of La Vita as they expand […]
More2023 LTC Pharmacy Market Update – How Inflation and Marginalized Patients Will Impact Values in The Coming Years
LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed, strategies reversed, and service transformed. The M&A landscape is now replete with both private equity-backed and independent operators scooping up quality businesses. At the same time, LTC facility M&A is speeding up after a slow […]
MoreHealthcare M&A Valuations Expected To Remain Strong In 2023 Despite Uncertainty
The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and 2022 proved to be record years for healthcare M&A, 2023 is expected to descend slightly, but still land above pre-pandemic levels. The industry’s overall strengths will endure, people need care, drugs, and medical devices in […]
MoreHarbor Healthcare Advises 5,100 Resident LTC Pharmacy On Its Sale & Partnership
Harbor Healthcare is pleased to announce the successful sale of a Southern California based long-term care pharmacy, servicing over 5,100 licensed assisted living and group home patients. The strategic acquirer maintains a nationwide presence in the long-term care space and this acquisition provides them with further penetration into the highly competitive Southern California market. The […]
MoreHow Economic Uncertainty Will Impact Pharmacy Valuations in 2023
The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and 2022 proved to be record years for healthcare M&A, 2023 is expected to descend slightly, but still land above pre-pandemic levels. The industry’s overall strengths will endure, people need care, drugs, and medical devices in […]
MoreHarbor Healthcare Advises Hopkinton Drug Compounding On Its Sale & Strategic Partnership
Harbor Healthcare Consultants is pleased to announce the successful sale of Hopkinton Drug Compounding Pharmacy, a Massachusetts-based 503A compounding pharmacy and leading provider of compounded therapies serving patients across 35 states. The transaction brings together two independent pharmacies and creates tremendous value for both buyer and seller. Combining their geographic footprints, the acquiring pharmacy will […]
More